FVII or FVIIa variants having increased clotting activity

Details for Australian Patent Application No. 2010201266 (hide)

International Classifications

Event Publications

22 April 2010 Application Open to Public Inspection

Published as AU-A-2010201266

22 April 2010 Complete Application Filed

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

2 August 2012 Section 223 Application Received

Bayer HealthCare LLC An application to extend the time from 26 Sep 2011 to 26 Apr 2012 in which to pay a continuation fee has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2012

20 September 2012 Section 223 Application Allowed

Bayer HealthCare LLC The time in which to pay a continuation fee has been extended to 26 Apr 2012 . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.